Violeta García-Hernández

5PUBLICATIONS
36CO-AUTHORS
Cancer cell biologyHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 03, 2026
Tight junction-high and CDH17-positive cell population is the source of colorectal cancer liver metastases.

Daniel Alvarez-Villanueva, María Maqueda, Dina Harti

|Nov 17, 2025
Human iPSCs-based modeling unveils SETBP1 as a driver of chromatin rewiring in GATA2 deficiency.

Joan Pera, Damia Romero-Moya, Eric Torralba-Sales

|Sep 22, 2023
IκB kinase-α coordinates BRD4 and JAK/STAT signaling to subvert DNA damage-based anticancer therapy.

Irene Pecharromán, Laura Solé, Daniel Álvarez-Villanueva

|Jan 04, 2023
β-Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T-cell acute lymphoblastic leukemia.

Violeta García-Hernández, David Arambilet, Yolanda Guillén

|Aug 06, 2021
Distinct roles for PARP-1 and PARP-2 in c-Myc-driven B-cell lymphoma in mice.

Miguel A Galindo-Campos, Nura Lutfi, Sarah Bonnin

Pageof 1

Frequent Collaborators

3 joint publications

Lluis Espinosa

3 joint publications

Anna Bigas

2 joint publications

Teresa Lobo-Jarne

2 joint publications

Ángela Montoto